MiNK Therapeutics stockholders elect directors, ratify KPMG at 2024 annual meeting

MiNK Therapeutics, Inc.

Annual meeting held June 12, 2024; 28,359,271 shares (81.71%) present or represented.
Brian Corvese and Peter Behner elected as Class III directors for three-year terms.
Ratification of KPMG LLP as independent auditor for FY2024 approved with 28,242,636 votes for.
Broker non-votes of 3,364,923 on director elections and none on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.